Wellbeing Digital Sciences (NEO:MEDI.AQN, OTCQB:KONEF) has announced the appointment of Dr Michael Ho as the new medical director of its MindScape Ketamine & Infusion Therapy Clinic in Houston, Texas, effective May 2, 2022, replacing Dr Quang Henderson who is retiring after founding the clinic in 2018.
The mental healthcare company said Ho serves as the director of Safe Sleep Anesthesia and is also the course director of Anesthesiology Consultants, both located in Houston, Texas, with an accumulation of over 20,000 hours of anesthesia instruction to his credit.
“We are excited to welcome Dr Ho to the MindScape facility and to Wellbeing overall, especially based on his impressive set of qualifications,” said Najla Guthrie, CEO of Wellbeing, in a statement.
“I would like to thank Dr Henderson for establishing MindScape and for his service to the company over the past year. I wish him well in his retirement and that he enjoys the next chapter of his life knowing that the clinic is in Dr Ho’s good hands.”
READ: Wellbeing Digital Sciences says IRP Health subsidiary approved as part of Chronic Pain Centre of Excellence for Canadian veterans
Ho, a graduate of Cornell University with a B.A. in Biochemistry and an M.D. from Washington University School of Medicine, with postgraduate training in pediatrics and anesthesiology, was staff physician at the University of Texas in the Department of Anesthesiology at Memorial-Hermann Hospital for 10 years and has over 20 years of teaching and working as an anesthesiologist.
Wellbeing noted that Ho has received many awards for excellence in teaching at the Baylor College of Medicine and The University of Texas Medical Branch, and has amassed 15 publications, seven onsite courses and 17 webinars.
Wellbeing acquired MindScape on April 21, 2021, and since then, the clinic has administered over 600 low-dose ketamine infusions to patients, which the company views as a significant milestone.
“Wellbeing is in the process of evaluating the addition of complementary mental health services being provided to patients at the clinic. The company has also recently implemented a new marketing strategy and intends to grow the local patient base by establishing connections with mental health practitioners in the area that have recognized the potential of the off-label use of ketamine in the treatment of mood disorders,” it added.
Ketamine has shown to have anti-depressant and anti-suicidal effects, and the possibility of ketamine treating mood disorders like bipolar is thought to be quite promising, Wellbeing said, noting recent studies.
Mindscape Ketamine & Infusions Therapy offers affordable delivery of concierge IV ketamine therapy for treatment-resistant mood disorders, mental health disorders, and chronic pain conditions.
Mindscape is the only IV ketamine clinic in Houston to offer virtual reality-based guided meditation to complement IV ketamine infusions in the treatment of depression, bipolar disorder, anxiety, PTSD, OCD, and other mood disorders.
Contact the author at jon.hopkins@proactiveinvestors.com